• HOME>
  • Investor Relations>
  • IR News>
  • Difference from Financial Forecasts for the Second Quarter of the Year Ending March 31, 2010 and Revision of Financial Forecasts for the Year Ending March 31, 2010

IR News

Oct. 29, 2009Print(PDF/78KB)Finances

Difference from Financial Forecasts for the Second Quarter of the Year Ending March 31, 2010 and Revision of Financial Forecasts for the Year Ending March 31, 2010

Dainippon Sumitomo Pharma Co., Ltd. announced the difference between financial results and forecasts for the second quarter of the year ending March 31, 2010.
In addition, the revision of financial forecasts for the year ending March 31, 2010 was announced.

(millions of yen)

1. Difference from Consolidated Financial Forecasts for the Second Quarter of the Year Ending March 31, 2010 (April 1, 2009 to September 30, 2009)

Net salesOperating
income
Ordinary
income
Net incomeEarnings
per share
(yen)
Previous forecasts(A) 130,600 12,800 12,400 7,800 ¥19.63
Results(B) 132,210 18,919 19,053 12,654 ¥31.85
(B-A) 1,610 6,119 6,653 4,854
Change(%) 1.2 47.8 53.7 62.2
(Reference)Results for the
six months ended
September 30, 2008
134,358 18,177 18,208 10,870 ¥27.35

2. Revision of Consolidated Financial Forecasts for the Year Ending March 31, 2010 (April 1, 2009 to March 31, 2010)

Net salesOperating
income
Ordinary
income
Net incomeEarnings
per share
(yen)
Previous forecasts(A) 264,000 25,000 24,000 15,000 ¥37.75
New forecasts(B) 264,000 29,000 27,000 18,000 ¥45.30
(B-A) 0 4,000 3,000 3,000
Change(%) 0.0 16.0 12.5 20.0
(Reference)Results for the
year ended March 31, 2009
264,037 31,166 31,395 19,987 ¥50.30

3. Difference from Non-Consolidated Financial Forecasts for the Second Quarter of the Year Ending March 31, 2010 (April 1, 2009 to September 30, 2009)

Net salesOperating
income
Ordinary
income
Net incomeEarnings
per share
(yen)
Previous forecasts(A) 121,600 12,800 12,500 7,700 ¥19.38
Results(B) 123,833 18,161 18,310 11,920 ¥30.00
(B-A) 2,233 5,361 5,810 4,220
Change(%) 1.8 41.9 46.5 54.8
(Reference)Results for the
six months ended
September 30, 2008
126,187 18,052 18,126 10,929 ¥27.50

4. Revision of Non-Consolidated Financial Forecasts for the Year Ending March 31, 2010 (April 1, 2009 to March 31, 2010)

Net salesOperating
income
Ordinary
income
Net incomeEarnings
per share
(yen)
Previous forecasts(A) 245,000 23,900 23,000 14,100 ¥35.49
New forecasts(B) 245,000 27,300 25,400 16,500 ¥41.53
(B-A) 0 3,400 2,400 2,400
Change(%) 0.0 14.2 10.4 17.0
(Reference)Results for the year ended March 31, 2009 248,433 30,582 30,893 19,729 ¥49.65

5. Reason for Difference and Revision

< Net sales >
Actual sales until the end of the second quarter have been nearly in line with the previous forecasts.
Accordingly, the previous forecasts for the full year have been unchanged.

< Operating income >
One of the Company's focused challenges in the year ending March 31, 2010 is to strive for efficient management and for efficient and profitable corporate structure. All the expenses are reexamined for the necessity and R&D expenses are spent efficiently based on prioritization. Owing to these efforts, coupled with the carry-over of R&D expenses and other expenses to the third quarter or later, actual operating income for the second quarter increased compared to the previous forecasts.

As to the full year, owing to efforts for the improvement in management efficiency and for the efficient and profitable corporate structure, the Company anticipates selling, general and administrative expenses, manufacturing costs and others to be reduced more than expected. Accordingly, the Company now forecasts increase in operating income by ¥4.0 billion compared to the previous forecasts.

< Ordinary income / Net income >
Although non-operating expenses such as interest expense are expected to increase due mainly to financing for the acquisition of Sepracor Inc., the Company now forecasts increase in ordinary income as well as net income by ¥3.0 billion compared to the previous forecasts.

It should be noted that the above forecasts do not include any performance figures of Sepracor Inc., which has recently become an indirect wholly-owned subsidiary of the Company. Goodwill and in-process R&D, etc. resulting from the acquisition are under evaluation at present, and their financial impact will be announced once determined.

Note: Forecasts shown above are based on management's assumptions and beliefs in light of the information currently available, and involve risks and uncertainties. Actual financial results may differ materially depending on a number of factors, including economic conditions.